Skip to main content

Want a detailed portfolio tracker?

VANI
NASDAQ
$1.35

Vivani Medical Inc (VANI)

Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery systems. The company specializes in biocompatible implants that facilitate sustained medication delivery, addressing pressing health challenges, particularly in diabetes and neurological disorders. With a strong product pipeline and an extensive intellectual property portfolio, Vivani is strategically positioned to tackle significant unmet medical needs, presenting an attractive opportunity for institutional investors looking to capitalize on advancements in the biopharmaceutical sector.
Website: https://www.vivani.com
Sector:
Healthcare
Industry:
Biotechnology
68 analysts
Strong Buy
Target: $3.83 (+183.93%)

Market Cap

$119M

FCF 5Y CAGR

+24.28%

Free Cash Flow Yield

-22.22%

Beta (5Y)

0.90

Price Chart

Valuation
Market Cap$119M
P/B6.33
Profitability
Gross Profit (TTM)$130K
EBITDA-$27M
EPS-$0.39
Financial Health
Free Cash Flow Yield-22.22%
Growth & Risk
FCF 5Y CAGR+24.28%
Beta (5Y)0.90
Sharpe Ratio0.08